Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator

被引:38
|
作者
Priviero, FBM [1 ]
Baracat, JS [1 ]
Teixeira, CE [1 ]
Claudino, MA [1 ]
De Nucci, G [1 ]
Antunes, E [1 ]
机构
[1] UNICAMP, Fac Med Sci, Dept Pharmacol, BR-13084971 Campinas, SP, Brazil
关键词
aorta; BAY; 41-2272; IH-[1,2,4]oxadiazolo[4, 3-a]quinoxalin-1-one; nitric oxide; sildenafil; soluble guanylate cyclase;
D O I
10.1111/j.1440-1681.2005.04262.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The compound BAY 41-2272 (5-cyclopropyl-2-[1-(2fluoro-benzyi)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4- ylamine) has been described as a potent, nitric oxide (NO)independent, stimulator of soluble guanylate cyclase. In the present study, the mechanisms underlying the relaxant effect of BAY 41-2272 in endothelium-intact and -denuded precontracted rabbit aortic rings were investigated. 2. Male New Zealand white rabbits were anaesthetized with pentobarbital sodium. Aortic rings were transferred to 10 mL organ baths containing oxygenated and warmed Krebs' solution. Tissues were connected to force-displacement transducers and changes in isometric force were recorded. Aortic rings were precontracted submaximally with phenylephrine (1 mu mol/L). 3. The addition of BAY 41-2272 (0.01-10 mu mol/L) to the organ bath produced concentration-dependent relaxations of the aortic rings with a higher potency in endothelium-intact (pEC(50) 6.59 +/- 0.05) compared with endothelium-denuded (pEC(50) 6.19 +/- 0.04; P < 0.05) preparations. No differences in maximal responses were observed in either preparation. The NO synthesis inhibitor N-G-nitro-L-arginine methyl ester (100 mu mol/L) produced a 2.1-fold rightward shift in endothelium-intact (P < 0.01) rings, but had no effect in endothelium-denuded rings. The soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; 1 mu mol/L) caused significant rightward shifts of the concentration-response curves to BAY 41-2272 of 4.9- and 2.6-fold in endothelium-intact and -denuded rings, respectively. The phosphodiesterase-5 inhibitor sildenafil (0.1 mu mol/L) significantly potentiated the relaxant effects of BAY 41-2272 in both endothelium-intact and -denuded rings. 4. At 1 mu mol/L, BAY 41-2272 significantly elevated the aortic cGMP content above basal levels in both endothelium-intact and -denuded rings. Furthermore, ODQ reduced BAY 41-2272-elicited increases in cGMP content by 17 and 90% in endothelium-intact and -denuded rings, respectively (P < 0.01). 5. In conclusion, BAY 41-2272 potently relaxes endothelium-intact and -denuded rabbit aortic rings. The basal release of endothelium-derived NO enhances BAY 41-2272-induced relaxations, suggesting a synergistic effect of BAY 412272 and NO on soluble guanylate cyclase. In addition, the endothelium-independent relaxation involves both GMP-dependent and -independent mechanisms.
引用
收藏
页码:728 / 734
页数:7
相关论文
共 50 条
  • [1] Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease
    Boerrigter, Guido
    Burnett, John C., Jr.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (01): : 30 - 45
  • [2] Mechanisms underlying rat mesenteric artery relaxation by BAY 41-2272, a nitric oxide-independent soluble guanylyl cyclase stimulator
    Teixeira, CE
    Webb, RC
    FASEB JOURNAL, 2004, 18 (04): : A596 - A597
  • [3] Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase
    Thomazzi, SM
    Moreira, J
    De Nucci, G
    Antunes, E
    BIOCHEMICAL PHARMACOLOGY, 2005, 69 (06) : 875 - 882
  • [4] Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272
    da Silva, Fabio H.
    Claudino, Mario A.
    Bau, Fernando R.
    Rojas-Moscoso, Julio A.
    Monica, Fabiola Z.
    De Nucci, Gilberto
    Antunes, E.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 688 (1-3) : 49 - 55
  • [5] Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells
    de Oliveira-Junior, Edgar Borges
    Thomazzi, Sara Maria
    Relider, Jussara
    Antunes, Edson
    Condino-Neto, Antonio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 567 (1-2) : 43 - 49
  • [6] Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle
    Toque, Haroldo A.
    Monica, Fabiola Z. T.
    Morganti, Rafael P.
    De Nucci, Gilberto
    Antunes, Edson
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 645 (1-3) : 158 - 164
  • [7] MECHANISMS OF RELAXANT ACTIVITY OF THE NITRIC OXIDE-INDEPENDENT SOLUBLE GUANYLYL CYCLASE STIMULATOR BAY 41-2272 IN ISOLATED HUMAN URETER: AN IN VITRO STUDY
    Miyaoka, Ricardo
    Monica, Fabiola
    de Nucci, Gilberto
    D'Ancona, Carlos
    Antunes, Edson
    JOURNAL OF UROLOGY, 2011, 185 (04): : E822 - E823
  • [8] Mechanism of relaxation and interaction with nitric oxide of the soluble guanylate cyclase stimulator BAY 41-2272 in mouse gastric fundus and colon
    Cosyns, Sarah M. R.
    Lefebvre, Romain A.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 686 (1-3) : 104 - 115
  • [9] Effect of Bay 41-2272, a Soluble Guanylate Cyclase Agonist, in Lymphocytes
    Wall Barbosa de Carvalho, Marina Uchoa
    Ferreira Rosa, Paola Vendramini
    Soeiro Pereira, Paulo Vitor
    Antunes, Edson
    Condino Neto, Antonio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S54 - S54
  • [10] Effect of BAY 41-2272, a soluble guanylate cyclase agonist, in lymphocytes
    Uchoa Wall Barbosa de Carvalho, M.
    Vendramini Ferreira Rosa, P.
    Soeiro Pereira, P., V
    Antunes, E.
    Condino Neto, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 137 - 137